Prolonging remission in AML: current approaches & future outlooks

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone... The post Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents appeared first on VJHemOnc.

This week’s podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from... The post Improving care for patients with SCD: pain management, ongoing projects & unmet needs appeared first on VJHemOnc.

In this podcast, experts Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, Nicole LeBoeuf, MD, MPH, Dana-Farber Cancer Institute,... The post Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care appeared first on VJHemOnc.

Today’s podcast episode focuses on the management of complications associated with Waldenström’s macroglobulinemia (WM), featuring expert insights from the 12th... The post Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more! appeared first on VJHemOnc.

This week’s podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the... The post CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024 appeared first on VJHemOnc.

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,... The post The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS appeared first on VJHemOnc.

Today’s podcast focuses on the role of BTK inhibitors (BTKis) in the treatment of mantle cell lymphoma (MCL). You will... The post Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events appeared first on VJHemOnc.

Menin inhibitors are emerging as a promising therapeutic approach in acute myeloid leukemia (AML), particularly in patients with specific genetic... The post An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more! appeared first on VJHemOnc.

Today’s podcast features discussions from the 21st International Workshop on Non-Hodgkin Lymphoma (iwNHL) which took place in Nice, France. You... The post CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024 appeared first on VJHemOnc.

Today’s podcast features a discussion with leading experts Harry Erba, MD, PhD, Duke University, Durham, NC, Farhad Ravandi, MD, The... The post Prolonging remission in AML: current approaches & future outlooks appeared first on VJHemOnc.